Stem cells, exosomes, gene therapy, peptides, hyperbaric oxygen, and epigenetic reprogramming
348 articles
China-based Immorna and another startup enter clinical trials testing RNA-based CAR-T treatments for autoimmune conditions.
Breakthrough technology allows precise activation of genes in living animals using electromagnetic fields, opening new therapeutic possibilities.
Major cancer research funder increases investment in mRNA vaccine technology while other developers pull back from the field.
FDA seeks additional cardiovascular and liver safety data for Eli Lilly's newly approved obesity medication Foundayo.
Bacteriophages could offer a breakthrough solution to combat the growing crisis of antibiotic-resistant infections threatening global health.
Explore the molecular mechanisms of cellular senescence and how p16/p21 pathways drive SASP production, plus cutting-edge senolytic drug targets.
Discover how revolutionary drugs target 'zombie cells' that accumulate with age, potentially reversing aging and extending healthspan.
Revolution Medicines' RAS inhibitor daraxonrasib shows breakthrough results in pancreatic cancer, doubling patient survival times.
BioNTech reports positive Phase 2 results for HER2-targeted cancer therapy, with FDA filing planned to compete with existing treatments.
New 'off-the-shelf' CAR-T therapy eliminated detectable lymphoma cells in over half of treated patients in early clinical data.
New approach to treating childhood wrist fractures may improve outcomes by prioritizing immediate casting over other interventions.
Researchers developed a new method to create aligned fibers from tendon tissue that maintain natural proteins and support cell growth.
